The fact that IM immunization developed a high level of serum antibodies but not detectable mucosal IgA with higher viral lung titer than IN route strongly indicates the essential role of the mucosal responses in SARS immunity [77]. This evidence concerns the gene CD79A and severe acute respiratory syndrome.